Could a simple pad replace invasive biopsies for uterine cancer?
NCT ID NCT06464107
First seen Feb 13, 2026 · Last updated Jun 22, 2026 · Updated 17 times
Summary
This study tested a special pad worn for 4-6 hours to collect cells shed from the uterus. Researchers wanted to see if the pad could gather enough cells to tell the difference between normal tissue, precancerous changes, and cancer. 80 women scheduled for surgery wore the pad, and the collected cells were analyzed in a lab. The goal is to find a less uncomfortable way to screen for endometrial cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
-
Riverview Medical Center
Red Bank, New Jersey, 07701, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PadKit™ (interlabial pad device)
What this could lead to
If successful, this could offer a simple, at-home method to screen for endometrial cancer or abnormal cell growth, reducing the need for invasive procedures.
What could go wrong
This is a small, completed study with 80 participants, so results may not apply to everyone. The pad may not collect enough cells for accurate diagnosis, and it is not yet proven to replace standard tests.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.